Qbrexza® Affordability Assistance
As of late 2018, the FDA-approved, topical anticholinergic wipe Qbrexza® was made available in the U.S. for use in the treatment of axillary hyperhidrosis.
Patients with a prescription for Qbrexza® should be able to get that prescription filled at local pharmacies including CVS and Walgreens stores or by mail order.
Qbrexza® is owned by Journey Medical Corporation. To help many axillary (underarm) hyperhidrosis patients* access Qbrexza®, there is a Patient Savings Card that patients* can receive in either of the following two ways:
- From you, their healthcare provider
- By downloading a card online
Once a patient has received a savings card, they should present it to their participating pharmacist, along with their insurance card and a valid prescription for Qbrexza.
Questions? Call 1-888-786-5876.
*Please note that the Qbrexza® Patient Savings Card "is valid ONLY for patients with commercial (private or non-governmental) insurance. Patients enrolled in Medicare, Medicaid, Medigap, TRICARE, the Department of Veterans Affairs healthcare program, or any other federal or state government-funded healthcare program (“Government Programs”) are not eligible." Eligible patients must be residents of the United States.
L74.5 - Focal Hyperhidrosis (L74.5 and L74.51 should not – however - be used for reimbursement purposes as there are multiple more specific codes)
L74.51 - Primary Focal Hyperhidrosis
L74.510 - Primary Focal Hyperhidrosis, Axilla
L74.511 - Primary Focal Hyperhidrosis, Face
L74.512 – Primary Focal Hyperhidrosis, Palms
L74.513 – Primary Focal Hyperhidrosis, Soles
L74.519 – Primary Focal Hyperhidrosis, Unspecified
L74.52 - Secondary Focal Hyperhidrosis
L74.8 - Other Eccrine Sweat Disorders
L74.9 - Eccrine Sweat Disorder Unspecified